المؤلفون: Shira Dinner, Ayman Saad, David J. Kuter, Lia Perez, Jennifer L. Burns, Raajit K. Rampal, Shiven B. Patel, Vivek Roy, Sudipto Mukherjee, James O. Armitage, Peter Westervelt, Mary Mably, Martha Wadleigh, Shannon Hough, Jeffrey Crawford, Julio C. Chavez, Ivana Gojo, Lee S. Schwartzberg, Thomas Fynan, Lenora A. Pluchino, Mahsa Talbott, Pamela S. Becker, Hope S. Rugo, Gary H. Lyman, Elizabeth A. Griffiths, Douglas W. Blayney, Dwight D. Kloth, Sepideh Shayani, Sumithira Vasu, Adam Poust, Saroj Vadhan-Raj, Peter T. Curtin

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN. 15(12)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Myeloid, Antineoplastic Agents, Neutropenia, Medical Oncology, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Neoplasms, medicine, Humans, Myeloid Cells, 030212 general & internal medicine, Risks and benefits, Chemotherapy-Induced Febrile Neutropenia, Myelosuppressive Chemotherapy, business.industry, Incidence (epidemiology), Incidence, medicine.disease, Clinical Practice, Regimen, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Intercellular Signaling Peptides and Proteins, business, Febrile neutropenia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06531fa0ba6ac7db4b3d879542081b5b
https://pubmed.ncbi.nlm.nih.gov/29223990